Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. State-of-the-art preclinical testing of the OMEGATM left atrial appendage occluder

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. First-in-human results of the OMEGA™ Left Atrial Appendage Occluder for Patients with Non-Valvular Atrial Fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device

    Research output: Contribution to journalLetterResearchpeer-review

  3. Contemporary management of severe symptomatic bicuspid aortic valve stenosis: the BiTri Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. State-of-the-art preclinical testing of the OMEGATM left atrial appendage occluder

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: Early discharge after transcatheter aortic valve implantation (TAVI) may potentially impact post-procedural safety of the patient. The study aim was to compare safety of TAVI in patients planned for fast track hospital stay with patients planned for standard hospital stay.

METHODS AND RESULTS: All-comers patients undergoing transfemoral TAVI between 2011 and 2017 were allocated to two matched groups depending whether the procedure was performed before or after transition from standard to fast track course. Data on vital status and hospitalizations were obtained through national registries. Three hundred and nineteen matched pairs were eligible for analysis. The median length of post-procedural stay was 3 days (IQR: 2-4) for patients in the fast track group compared to 6 days (IQR: 4-8) in the standard approach group (p < .0001). There was no difference in all-cause mortality between groups at 30-day (1.3% vs. 1.9%, p = .52) or 90-day follow-up (2.9% vs. 4.1%, p = .42). There was no difference in the risk of new permanent pacemaker implantation (PPI) in pacemaker naïve patients between groups at 30-day (15.8% vs. 21.2%, p = .16) or 90-day follow-up (15.8% vs. 21.9%, p = .12). There was no difference in the rate of rehospitalization between groups between discharge and 90-day follow-up (2.09 per patient-year vs. 2.09 per patient-year, p = .99).

CONCLUSIONS: Early discharge in an all-comers population undergoing transfemoral TAVI is safe with regards to all-cause mortality, need for PPI, and rehospitalization.

Original languageEnglish
JournalCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Volume98
Issue number2
Pages (from-to)E282-E290
ISSN1522-1946
DOIs
Publication statusPublished - 1 Aug 2021

    Research areas

  • aortic stenosis, discharge, mortality, pacemaker, transcatheter aortic valve implantation

ID: 62239365